Saad Muzaffar Azeem, et al. “OPTIMIZING AMINOGLYCOSIDE DOSING IN CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE PATIENTS UNDERGOING INTERMITTENT HEMODIALYSIS: CARDIOVASCULAR IMPLICATIONS AND CLINICAL OUTCOMES”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 33, no. 2, July 2026, pp. 1139-4, https://doi.org/10.69980/bn50yg38.